CAS 2259884-03-Zero Mazdutid Peptide

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of US$ 65/Box
Request Sample
Manufacturer/Factory

360° Virtual Tour

Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Experienced Team
The supplier has 6 foreign trading staff(s) and 3 staff(s) with over 6 years of overseas trading experience
Patents Awarded
The supplier had awarded 1 patents, you can check the Audit Report for more information
to see all verified strength labels (11)
  • CAS 2259884-03-Zero Mazdutid Peptide
  • CAS 2259884-03-Zero Mazdutid Peptide
  • CAS 2259884-03-Zero Mazdutid Peptide
  • CAS 2259884-03-Zero Mazdutid Peptide
  • CAS 2259884-03-Zero Mazdutid Peptide
  • CAS 2259884-03-Zero Mazdutid Peptide
Find Similar Products

Basic Info.

Model NO.
FLZ-S0902Mazdutid
Suitable for
Elderly, Children, Adult
State
Lyophilized Powder
Purity
>99%
Appearance
White Powder
Shelf Life
2 Years
Test Method
HPLC
MOQ
1box
Storage
Store Cool Dry Place
Resource
Natural
Quality Requirement
Strictly Quality Control
Market
Worldwide
Service
Welcome to Visit Us
Delivery Time
7-10days
Transport Package
Foil Bag
Specification
99%
Trademark
Xi′an Frazer Biotech Co., Ltd.
Origin
China
Production Capacity
200box/Month

Product Description

 CAS 2259884-03- zero  Mazduti Peptide
CAS 2259884-03-Zero Mazdutid Peptide

CAS 2259884-03-Zero Mazdutid Peptide

 
Description:

What is Maz?

Mazduti is a dual glucagon-like peptide 1 receptor agonist and glucagon receptor agonist, the first in its class. By activating both GL 1R and glucagon receptors it helps regulate appetite, metabolism, and improve glucose control. This dual effect appears promising but more clinical trials are needed.

Glucagon receptor agonists on their own are not a good therapeutic option because they increase the liver's production of glucose, but if they are combined with GLs then they are effective at reducing fat mass and improving glucose tolerance.


BENEFITS OF MAZDUTIDE AGONISTS
  • Helps slow food leaving your stomach
  • Helps prevent your liver from making too much sugar
  • Helps the pancreas produce more insul when your blood sugar levels are high
  • Can help control blood glucose
  • Can reduce hyperglycemia, especially after meals
  • Can reduce fasting insul and fasting glucose
  • Can reduce hemoglobin A1c
  • Can decrease appetite and caloric intake, while inhibiting weight gain
  • Has been shown to lower triglyceride levels and oxidative stress from high LDL
  • Has been shown to help induce weight loss in obese patients with higher dosing
  • Helps decrease leptin and increase leptin sensitivity
  • Can increase the conversion of white fat to brown fat

GENERIC HOT PEPTIDES

# Product Sequence Therapeutic Area Form Unit Size
4109712 Semaglu
CAS No.: 910463-68-ll
H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH Type II diabetes mellitus
Obesity
Lyophilized powder 2 mg/vial
5 mg/vial
10 mg/vial
15 mg/vial
20 mg/vial
4109713 Tirze
CAS No.: 2023788-19-ll
H-Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-{diacid-gamma-Glu-(AEEA)2-Lys}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 Type II diabetes mellitus
Obesity
Lyophilized powder 10 mg/vial
15 mg/vial
20 mg/vial
30 mg/vial
60 mg/vial
4109714 Cagr
CAS No.: 1415456-99-
{Eicosanedioic acid-γ-Glu}-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Glu-Phe-Leu-Arg-His-Ser-Ser-Asn-Asn-Phe-Gly-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Pro-NH2 Type II diabetes mellitus
Obesity
Lyophilized powder 5 mg/vial
10 mg/vial
4109715 Cagri Sema Blend Type II diabetes mellitus
Obesity
Lyophilized powder 5 mg/vial
10 mg/vial
20 mg/vial
4109716 Reta
CAS No. 2381089-83-ll
Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{α-Me-Leu}-Leu-Asp-Lys-{diacid-C20-gamma-Glu-(AEEA)-Lys}-Ala-Gln-{Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 Treatment of type 2 diabetes
Treatment of obesity
Lyophilized powder 8 mg/vial
10 mg/vial
12 mg/vial
15 mg/vial
30 mg/vial
  • CAS 2259884-03-Zero Mazdutid PeptideCAS 2259884-03-Zero Mazdutid Peptide
CAS 2259884-03-Zero Mazdutid Peptide

 

CAS 2259884-03-Zero Mazdutid Peptide

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier